Literature DB >> 2159524

Extra mouse mammary tumor proviruses in DBA/2 mouse lymphomas acquire a selective advantage in lymphocytes by alteration in the U3 region of the long terminal repeat.

S Yanagawa1, A Murakami, H Tanaka.   

Abstract

We determined the nucleotide sequences of the long terminal repeats (LTRs) from mouse mammary tumor virus (MMTV) proviruses acquired in two DBA/2 mouse lymphoma cell lines, MLA and DL-8. Proviruses from MLA contained a 352-base-pair deletion from nucleotides 669 to 1020 in the U3 region of the LTR, whereas the LTR alteration of the DL-8 provirus involved both a similar 360-base-pair deletion and generation of a tandem repeat region consisting of sequences of flanking deletions. To assess the function of the rearranged LTRs, we constructed plasmids in which normal and rearranged LTRs drove the reporter chloramphenicol acetyltransferase gene and transfected them into T-cell lines (Jurkat, Molt-3, and DL-8) and the mammary tumor cell line T47D. Both rearranged LTRs were transcriptionally active, but normal LTRs were not active in either the presence or absence of glucocorticoids in all T-cell lines. In T47D cells, however, the MLA provirus LTR showed the same glucocorticoid- or progestin-dependent transcriptional activity as did normal LTRs. The DL-8 provirus LTR acquired a novel enhancer(s) by rearrangement and thus had a high basal transcriptional activity in T47D cells. The results of chloramphenicol acetyltransferase assays using plasmids with various chimeric MMTV LTRs revealed that the rearranged LTRs had lost their negative regulatory element and contained an enhancer element that was highly homologous to the enhancer A element of polyomavirus (from nucleotides 525 to 558). GR but not C3H mouse MMTV contained this enhancer. These results elucidate some of the molecular mechanisms involved in the selection of mutant MMTVs with rearranged LTRs in lymphoma cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159524      PMCID: PMC249422          DOI: 10.1128/JVI.64.6.2474-2483.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Transcriptional repression of a hormone-responsive promoter.

Authors:  K L Morley; M G Toohey; D O Peterson
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

2.  Multiple regulatory domains in the mouse mammary tumor virus long terminal repeat revealed by analysis of fusion genes in transgenic mice.

Authors:  T A Stewart; P G Hollingshead; S L Pitts
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

3.  The c-Ha-ras oncogene and a tumor promoter activate the polyoma virus enhancer.

Authors:  C Wasylyk; J L Imler; J Perez-Mutul; B Wasylyk
Journal:  Cell       Date:  1987-02-13       Impact factor: 41.582

4.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements.

Authors:  W Lee; P Mitchell; R Tjian
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

5.  Exogenous mouse mammary tumor virus proviral DNA isolated from a kidney adenocarcinoma cell line contains alterations in the U3 region of the long terminal repeat.

Authors:  R J Wellinger; M Garcia; A Vessaz; H Diggelmann
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

6.  Site-specific rearrangements in the long terminal repeat of extra mouse mammary tumor proviruses in murine T-cell leukemias.

Authors:  R Michalides; E Wagenaar
Journal:  Virology       Date:  1986-10-15       Impact factor: 3.616

7.  Alterations in the U3 region of the long terminal repeat of an infectious thymotropic type B retrovirus.

Authors:  J K Ball; H Diggelmann; G A Dekaban; G F Grossi; R Semmler; P A Waight; R F Fletcher
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

8.  Structural and functional analysis of long terminal repeats of Suncus murinus mammary tumor virus.

Authors:  S Yanagawa; A Murakami; M Hoshino; H Tanaka
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

9.  Glucocorticoid-resistant lymphoma cell variants that contain functional glucocorticoid receptors.

Authors:  S K Rabindran; M Danielsen; M R Stallcup
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

10.  The hormone regulatory element of mouse mammary tumour virus mediates progesterone induction.

Authors:  A C Cato; R Miksicek; G Schütz; J Arnemann; M Beato
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

View more
  21 in total

1.  The c-myc locus is a common integration site in type B retrovirus-induced T-cell lymphomas.

Authors:  L Rajan; D Broussard; M Lozano; C G Lee; C A Kozak; J P Dudley
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Mouse Mammary Tumor Virus Proviral Integration in the DD/Tbr Mice.

Authors: 
Journal:  Breast Cancer       Date:  1994-07-30       Impact factor: 4.239

Review 3.  Factors controlling the expression of mouse mammary tumour virus.

Authors:  W H Günzburg; B Salmons
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

4.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

5.  Identification of a novel mammary cell line-specific enhancer element in the long terminal repeat of mouse mammary tumor virus, which interacts with its hormone-responsive element.

Authors:  S Yanagawa; H Tanaka; A Ishimoto
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

6.  Chromosomal localization of acquired MMTV proviral integration sites in T-cell lymphomas.

Authors:  L Rajan; C A Kozak; J P Dudley
Journal:  Mamm Genome       Date:  1998-01       Impact factor: 2.957

7.  Ku antigen-DNA conformation determines the activation of DNA-dependent protein kinase and DNA sequence-directed repression of mouse mammary tumor virus transcription.

Authors:  W Giffin; W Gong; C Schild-Poulter; R J Haché
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

8.  Synergistic action of GA-binding protein and glucocorticoid receptor in transcription from the mouse mammary tumor virus promoter.

Authors:  K Aurrekoetxea-Hernández; E Buetti
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

9.  Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1.

Authors:  J A Mertz; F Mustafa; S Meyers; J P Dudley
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

10.  An activation-dependent, T-lymphocyte-specific transcriptional activator in the mouse mammary tumor virus env gene.

Authors:  C L Miller; R Garner; V Paetkau
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.